¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"alpha cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
bipolar cell
µÎ±Ø¼¼Æ÷
blast cell
¸ð¼¼Æ÷
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
blood cell separator
Ç÷±¸ºÐ¸®±â
bone marrow-derived cell
°ñ¼öÀ¯·¡¼¼Æ÷
border cell
°æ°è¼¼Æ÷, ¼Ó°æ°è¼¼Æ÷
balloon cell
dz¼±¼¼Æ÷
balloon cell nevus
dz¼±¼¼Æ÷¸ð¹Ý
bristle cell
¾ï¼¾Åм¼Æ÷, °¸ð¼¼Æ÷
burr cell
¹«µòÅ鳯ÀûÇ÷±¸
ciliated cell
¼¶¸ð¼¼Æ÷
clear cell
Åõ¸í¼¼Æ÷
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, Åõ¸í¼¼Æ÷±Ø¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾, Åõ¸í¼¼Æ÷¼±¾ÏÁ¾
clear cell carcinoma
Åõ¸í¼¼Æ÷¾ÏÁ¾
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
Schwann's cell
½Å°æÁý¼¼Æ÷
signet ring cell carcinoma
¹ÝÁö¼¼Æ÷¾ÏÁ¾
signet-ring cell
¹ÝÁö¼¼Æ÷
small cell carcinoma
¼Ò¼¼Æ÷¾ÏÁ¾
spindle cell
¹æÃß¼¼Æ÷
squamous cell carcinoma
ÆíÆò¼¼Æ÷¾ÏÁ¾
squamous cell in situ carcinoma
ÆíÆò¼¼Æ÷»óÇdz»¾ÏÁ¾, ÆíÆò¼¼Æ÷¾ÏÁ¾
stellate cell
º°¼¼Æ÷
stem cell
Áٱ⼼Æ÷
supporting cell
¹öÆÀ¼¼Æ÷
sustentacular cell
(¢¡supporting cell) ¹öÆÀ¼¼Æ÷
target cell
Ç¥Àû¼¼Æ÷
transitional cell
ÀÌÇ༼Æ÷
transitional cell carcinoma
ÀÌÇ༼Æ÷¾ÏÁ¾
cell line
¼¼Æ÷ÁÖ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
basosquamous cell carcinoma
¹Ù´ÚÆíÆò¼¼Æ÷¾ÏÁ¾, ±âÀúÆíÆò¼¼Æ÷¾ÏÁ¾
beta cell
º£Å¸¼¼Æ÷
bipolar cell
µÎ±Ø¼¼Æ÷
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
blood cell separator
Ç÷±¸ºÐ¸®±â
bone marrow-derived cell
°ñ¼öÀ¯·¡¼¼Æ÷
border cell
°æ°è¼¼Æ÷, ¼Ó°æ°è¼¼Æ÷
bristle cell
¾ï¼¾Åм¼Æ÷, °¸ð¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
alpha-sympathomimetic agent
¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
alpha-thalassemia trait
¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
alpha/beta (¥á/¥â) ratio
¥á/¥â ºñ
galactosidase, alpha-galactosidase a, deficiency
#NAME?
glucosidase, alpha -1,4-glucosidase
-1,4-±Û·çÄڽõ¥À̽º
glucosidase, alpha-glucosidase(acid maltase)
-±Û·çÄڽõ¥À̽º, -glucosidase
inter-alpha-trypsin inhibitor
ÀÎÅÍ-¾ËÆÄ-Æ®¸³½Å ¾ïÁ¦Á¦
reductase, 5-alpha-reductase inhibitor
5a-ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(¡ü½êªý£áÈåäð¤ð¥),5a-¸®´öÅ×À̽º¾ïÁ¦Á¦(¡åäð¤ð¥)
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
A cell
A ¼¼Æ÷
B cell
B¼¼Æ÷(~ á¬øà)
B cell
B ¼¼Æ÷
B cell
B ¼¼Æ÷.
B cell antigen
B ¼¼Æ÷Ç׿ø
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
alpha-naphthyl acetate esterase
¾ËÆÄ-³ªÇÁÆ¿¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl acetate esterase =ANAE
¾ËÆÄ¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl butyrate esterase
¾ËÆÄ-³ªÇÁÆ¿ ºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl butyrate esterase =ANBE
¾ËÆÄºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthylamine
¾ËÆÄ-³ªÇÁÆ¿¾Æ¹Î
alpha-sympathomimetic agent
¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
alpha-thalassemia trait
¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
alpha/beta (¥á/¥â) ratio
¥á/¥â ºñ
angle alpha
¾ËÆÄ°¢
chain, alpha (¥á)
¾ËÆÄ»ç½½, ¾ËÆÄ¼â
cowpea(alpha-borne) mosaic virus
Ä«¿ìÇÇ ¸ðÀÚÀÌÅ©¹ÙÀÌ·¯½º
galactosidase, alpha-galactosidase a, deficiency
#NAME?
glucosidase, alpha -1,4-glucosidase
-1,4-±Û·çÄڽõ¥À̽º
glucosidase, alpha-glucosidase(acid maltase)
-±Û·çÄڽõ¥À̽º, -glucosidase
inter-alpha-trypsin inhibitor
ÀÎÅÍ-¾ËÆÄ-Æ®¸³½Å ¾ïÁ¦Á¦
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½